You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibody Drug Conjugate

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)

Completed
  • Prostatic Neoplasms
  • +3 more
  • Exercise
  • Ghent, Oost-Vlaanderen, Belgium
    University Hospital ghent
Dec 22, 2022

Clear Cell Renal Cell Carcinoma Trial in Baltimore (Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 10, 2020

Hypertension, Public Health; Nursing Staff Trial in Karaman (Nursing interventions based on protection motivation theory in

Not yet recruiting
  • Hypertension, Public Health; Nursing Staff
  • Nursing interventions based on protection motivation theory in patients with hypertension
  • Karaman, Turkey
    Family Health Center No. 7 affiliated with Karaman Provincial He
Aug 10, 2023

Valvular Heart Disease, Valvular Stenosis, Valvular Insufficiency Trial in Tunis (Valve replacement)

Active, not recruiting
  • Valvular Heart Disease
  • +2 more
  • Valve replacement
  • Tunis, Tunisia
    The Tunisian Society of Cardiology and CardioVascular Surgery
Mar 31, 2022

Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%

Recruiting
  • Glaucoma
  • OHT - Ocular Hypertension
  • Timolol 0.5% ophthalmic solution
  • Latanoprost 0.005% Ophthalmic Solution
  • Rochester, Minnesota
  • +2 more
Jul 15, 2022

Advanced Cancers Trial in Houston (MABp1)

Completed
  • Advanced Cancers
  • Houston, Texas
  • +1 more
Feb 12, 2021

Herpes Simplex, HIV Trial in United States (Trifluridine, Bacitracin zinc/Polymyxin B sulfate)

Completed
  • Herpes Simplex
  • HIV Infections
  • San Francisco, California
  • +7 more
Oct 26, 2021

COVID-19 Trial in Beijing ([14C]STI-1558)

Not yet recruiting
  • COVID-19
  • Beijing, China
    Beijing Gaobo Boren Hospital
Mar 1, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage III NSCLC, Stage IIIA NSCLC Trial in Chicago, Lake Forest (other, drug,

Active, not recruiting
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
  • +1 more
Sep 20, 2020

Cervical Cancer Trial in Nanning (tislelizumab, concurrent chemoradiotherapy)

Not yet recruiting
  • Cervical Cancer
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 22, 2022

Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)

Recruiting
  • Peripheral T Cell Lymphoma
  • ATLCAR.CD30 T cells
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Mar 4, 2022

Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

Recruiting
  • Thyroid Carcinoma
  • +5 more
  • I-124 PET/CT lesion dosimetry
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Nantes Cedex 1, France
  • +19 more
Aug 11, 2022

Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s), Expansion Part: Prostate Cancer, Expansion Part: Esophageal

Terminated
  • Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s)
  • +7 more
  • GEN1044 is an IgG1 bispecific antibody targeting CD3 and 5T4.
  • Nashville, Tennessee
  • +5 more
Mar 1, 2022

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus
  • (no location specified)
Dec 12, 2022

Substance-Related Disorders, Opioid-Related Disorders, Behavior Therapy Trial in Berkeley, Chicago, Wauwatosa (App + Inputs

Completed
Has Results
  • Substance-Related Disorders
  • +2 more
  • App + Inputs Contingency Management
  • App + Outcomes Contingency Management
  • Berkeley, California
  • +2 more
Nov 16, 2022

Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

Recruiting
  • Metastatic Cancer
  • +5 more
  • Stereotactic Body Radiotherapy
  • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
  • Hartford, Connecticut
  • +9 more
Nov 17, 2022

Healthy Trial in New York (Perampanel 6 MG)

Active, not recruiting
  • Healthy
  • Perampanel 6 MG
  • New York, New York
    Neurophysiology Laboratory
Dec 20, 2022

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn
  • Angiosarcoma
  • (no location specified)
Dec 21, 2021

HIV Trial in United States (Ribavirin)

Completed
  • HIV Infections
  • San Diego, California
  • +4 more
Oct 28, 2021

HIV/AIDS Trial in Bangkok (N-803)

Recruiting
  • HIV/AIDS
  • Bangkok, Thailand
    Thai Red Cross AIDS Research Centre
Oct 4, 2021

Diabetic Neuropathic Pain, Healthy Volunteers Trial in Fukuoka (BAY2395840)

Recruiting
  • Diabetic Neuropathic Pain
  • Healthy Volunteers
  • Fukuoka, Japan
    SOUSEIKAI Fukuoka Mirai Hospital
Jan 10, 2023

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020